emirates7 - Boston Scientific, the global medical technology leader, inaugurated their new offices in the UAE at Dubai Science Park (DSP), the leading science-focused community part of TECOM Group, to meet the growing needs of patients in the Middle East.
Boston Scientific UAE entity’s expansion aims to address the significant increase in demand for medical devices in the region, which according to Business Market Insights, is expected to reach US$21,802.3 million in 2027.
Marwan Abdulaziz Janahi, Managing Director of DSP, commented, "Dubai is on track to becoming a global healthcare destination with state-of-the-art infrastructure and government support, and brands like Boston Scientific play an essential role in driving research, investment and insights.
"We are delighted to be a part of Boston Scientific’s growth story since they joined our ecosystem in 2018, and deeply share their mission to improve the lives of patients across the region. We will continue enhancing our enabling ecosystem and enrich the opportunities available to our existing and potential business partners in our mission to advance our national healthcare goals."
Eric Thepaut, Executive Vice President and President EMEA at Boston Scientific, said, "Strengthening our presence in the region will enable our teams to operate more efficiently and raise awareness of our innovative solutions for a wide range of therapy areas."
Boston Scientific UAE entity’s expansion aims to address the significant increase in demand for medical devices in the region, which according to Business Market Insights, is expected to reach US$21,802.3 million in 2027.
Marwan Abdulaziz Janahi, Managing Director of DSP, commented, "Dubai is on track to becoming a global healthcare destination with state-of-the-art infrastructure and government support, and brands like Boston Scientific play an essential role in driving research, investment and insights.
"We are delighted to be a part of Boston Scientific’s growth story since they joined our ecosystem in 2018, and deeply share their mission to improve the lives of patients across the region. We will continue enhancing our enabling ecosystem and enrich the opportunities available to our existing and potential business partners in our mission to advance our national healthcare goals."
Eric Thepaut, Executive Vice President and President EMEA at Boston Scientific, said, "Strengthening our presence in the region will enable our teams to operate more efficiently and raise awareness of our innovative solutions for a wide range of therapy areas."